The Union Health Ministry has amended the Drugs Rules, 1945, to let licensing authorities bar applicants who submit fake or fabricated data. The action requires a show-cause notice and allows an appeal.…
Dabur India said its Silvassa pharmaceutical plant remains operational after the US Food and Drug Administration issued a warning over manufacturing deficiencies. The company said the action affects a small private-label operation…
A Rajya Sabha commerce committee has urged the government to conclude the proposed India-US Bilateral Trade Agreement quickly, while protecting Indian exporters. It recommended seeking complete exemption from future US tariff increases…
Aurobindo Pharma’s consolidated net profit rose 25.2% year on year to Rs 1,032 crore in the June quarter of FY27, The Hindu reports. Revenue from operations increased 16.3% to Rs 9,150 crore,…
Lupin reported a consolidated net profit of Rs 1,415 crore for the June quarter, up 16% from a year earlier and above the Bloomberg estimate of Rs 1,350 crore, NDTV Profit reported.…
